SCHEMBL352397

SCHEMBL352397

Cn1nccc1[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23607781 0.86
SCHEMBL28155998 0.74
SCHEMBL11716245 0.74 LMNA (0.41)
SCHEMBL19098523 0.74 ALDH1A1 (0.36)
SCHEMBL27670021 0.74 ALDH1A1 (0.33)
SCHEMBL27687044 0.72 HTT (0.33)
SCHEMBL27667994 0.71 SIRT6 (0.41)
SCHEMBL3450422 0.71 CYP19A1 (0.47)
SCHEMBL16943122 0.71 MAPK1 (0.32)
SCHEMBL5946645 0.70 CYP19A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127078-B Heterocompounds and methods of use thereof 重庆复创医药研究有限公司 2024-03-01 CN disclosed
CN-108026065-A Indazole and azaindazole compounds as IRAK-4 inhibitors 奥列基因发现技术有限公司 2018-05-11 CN disclosed
CN-105452233-B Piperidine and azepane derivatives as prokineticin receptor modulators 武田药品工业株式会社 2017-12-08 CN disclosed
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 EP disclosed
EP-2222647-B1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2015-08-05 EP disclosed
EP-2684874-A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors Cephalon, Inc. (US) 2014-01-15 EP disclosed
US-8552186-B2 Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors CEPHALON, INC. (US) 2013-10-08 US disclosed
CN-101535276-B 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC 2013-08-28 CN disclosed
CN-102712635-A 1h-pyrazolo [3,4-b] pyridine compounds for inhibiting RAF kinase ARRAY BIOPHARMA INC 2012-10-03 CN disclosed
US-20120165519-A1 Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors CEPHALON, INC. (US) 2012-06-28 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2010096115-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROL OF HEPATITIS C VIRAL INFECTIONS APATH, LLC (US) 2010-08-26 WO disclosed
CN-101535276-A 2, 4-diaminopyrimidine fused bicyclic derivatives as ALK and c-MET inhibitors CEPHALON INC (US) 2009-09-16 CN disclosed
US-20090221555-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS CEPHALON, INC. (US) 2009-09-03 US disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed
US-20060211636-A1 Macrolide Antibiotics ALIHODZIC SULEJMAN 2006-09-21 US disclosed
US-20050215495-A1 Macrolide antibiotics ALIHODZIC SULEJMAN 2005-09-29 US disclosed
CN-1167405-C Keratin fibre dyeing composition containing pyrazolo-(1,5-alpha)-pyrimidine derivatives, dyeing method, pyrazolo-(1,5-alpha) pyrimidine new-type derivatives and preparation method thereof �ź㴫 2004-09-22 CN disclosed
CN-1196673-A Keratin fibre dyeing composition containing pyrazolo-(1,5-alpha)-pyrimidine derivatives, dyeing method, pyrazolo-(1,5-alpha) pyrimidine new-type derivatives and preparation method thereof OREAL (FR) 1998-10-21 CN disclosed